Vimarsana
Biggest News Aggregation in the World

Page 4 - Clinical Features News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Features. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Features Today - Breaking & Trending Today

Botulism - Causes, Types, Clinical Features, Management & Prevention - Vimarsana News

Botulism - Causes, Types, Clinical Features, Management & Prevention

Botulism is a rare but potentially lethal illness caused by botulinum neurotoxin released by the bacterium Clostridium botulinum into contaminated food, or wounds. The bacteria thrive in certain foods, wounds, and in the soil.

Neuroblastoma - Causes, Symptoms, Diagnosis & Treatment - Vimarsana News

Neuroblastoma - Causes, Symptoms, Diagnosis & Treatment

Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells [neuroblasts] of the sympathetic nervous system outside the brain.

Childhood Lupus Severity Linked to Social Determinants of Health - Vimarsana News

Childhood Lupus Severity Linked to Social Determinants of Health

Social determinants of health were linked to lupus disease severity in children, but it will take more than awareness among doctors to address the clinical implications of these findings.

Hyperprogressive Disease during Anti-PD-1/PD-L1 Treatment - Vimarsana News

Hyperprogressive Disease during Anti-PD-1/PD-L1 Treatment

Exploring predictive nomogram for hyperprogressive disease during anti-PD-1/PD-L1 treatment in patients with advanced non-small cell lung cancer. Click to read

Takeda's QDENGA▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union - Vimarsana News

Takeda's QDENGA▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

08.12.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in ...